SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Earnings per share
5Y CAGR
-45.6%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 0.22 | +106.0% |
| 2024 | -3.68 | +51.8% |
| 2023 | -7.64 | -77.3% |
| 2022 | -4.31 | -9.4% |
| 2021 | -3.94 | -185.1% |
| 2020 | 4.63 | +2204.5% |
| 2019 | -0.22 | - |